REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – A number of new therapies are currently in development for the treatment of MS. In part two of this two-part article, we summarize the most recent data presented at the World Congress. (See Emerging MS therapies Part I for information on cladribine, teriflunomide and fingolimod.)
Read More
Neurology
New MS atlas unveiled
November 4, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – The World Health Organization and the MS International Federation released its new Atlas of MS Resources in the World 2008 at the World Congress.
Read More
Emerging MS therapies Part I
November 4, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – A number of new therapies with novel mechanisms of action are currently in development for the treatment of MS.
Read More
Relapse severity, location predict characteristics of subsequent relapses
November 4, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – The severity and location of an MS relapse, and the degree of recovery from the attack, will predict the severity and location of subsequent attacks, according to an analysis by Dr. Emmanuelle Waubant, University of California, San Francisco (Waubant E. Abstract 48. Mult Scler 2008;14(suppl 1): S18).
Genetic factors may influence tauopathy, AD risk
October 21, 2008REPORT FROM THE ENS 2008 – The tau protein stabilizes microtubules but is believed to contribute to the development of neurofibrillary tangles when it becomes hyperphosphorylated.
Read More